What is the recommended use and dosage of Duloxetine (Serotonin-Norepinephrine Reuptake Inhibitor)?

Duloxetine: Recommended Use and Dosing

Approved Indications

Duloxetine is FDA-approved for major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain (osteoarthritis and chronic low back pain). 1

---

Standard Dosing Regimen

Initial Titration Strategy

Start duloxetine at 30 mg once daily for 1 week, then increase to the therapeutic dose of 60 mg once daily. 2, 3, 1

• This titration approach significantly reduces treatment-emergent nausea (the most common adverse effect) while producing only a transient delay in therapeutic effect compared to starting at 60 mg daily 2, 4
• The 30 mg starting dose allows patients to adjust to the medication before reaching the therapeutic dose 2, 3

Target Therapeutic Dose

The evidence-based therapeutic dose is 60 mg once daily for all chronic pain conditions. 3, 5, 1

• For diabetic peripheral neuropathic pain: 60 mg once daily is the recommended dose, with no evidence that higher doses confer additional significant benefit 5, 1, 6
• For fibromyalgia: 60 mg once daily is effective, with no evidence that doses greater than 60 mg/day provide additional benefit 1, 6
• For chronic musculoskeletal pain (osteoarthritis and low back pain): 60 mg once daily is the recommended dose 3, 1
• For major depressive disorder: 40-60 mg/day is the approved dose range, though 120 mg/day has been shown effective, there is no evidence that doses greater than 60 mg/day confer additional benefits 1, 7

---

Maximum Dosing

Do not exceed 60 mg once daily for pain conditions, as higher doses are associated with increased adverse effects without additional efficacy. 5, 1, 6

• While 120 mg daily has been studied and shown effective for depression and anxiety, higher doses clearly increase adverse event rates without improving pain outcomes 8, 1, 6

---

Special Populations

Geriatric Patients

In elderly patients with generalized anxiety disorder, start at 30 mg once daily for 2 weeks before increasing to 60 mg daily. 1

• Geriatric patients require lower starting doses and slower titration 2, 3

Renal Impairment

Avoid duloxetine in patients with severe renal impairment (creatinine clearance <30 mL/min). 2, 1

• For patients with renal insufficiency not meeting severe criteria, consider a lower starting dose and gradual titration 3, 1

Hepatic Impairment

Avoid duloxetine in patients with chronic liver disease or cirrhosis. 2, 1

• Dose reduction is required in hepatic disease 2

Chemotherapy-Induced Peripheral Neuropathy

For chemotherapy-induced peripheral neuropathy, use 30 mg daily for 1 week, then increase to 60 mg daily. 2

• Better response has been demonstrated in cisplatin-treated patients compared to taxane-treated patients 2

---

Administration Guidelines

How to Take

Administer duloxetine orally with or without meals and swallow capsules whole. 1

• Do not chew, crush, or open the delayed-release capsule, as this affects the enteric coating 1
• Do not sprinkle contents on food or mix with liquids 1

Missed Dose

If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. 1

• Skip the missed dose if the next dose is due soon 1
• Never take two doses at the same time 1

---

Monitoring Requirements

Essential Monitoring

Monitor blood pressure at each follow-up visit, as duloxetine can cause modest hypertension. 2

• Assess for adverse effects at each follow-up visit, particularly those related to higher doses 2
• Evaluate therapeutic response using standardized pain or depression scales 2
• Watch closely for mood changes, particularly in young adults during the first few months of treatment 2

Laboratory Monitoring

Routine aminotransferase monitoring is generally unnecessary. 3

• Duloxetine does not typically produce clinically important electrocardiographic or blood pressure changes 3

---

Discontinuation Protocol

Tapering Strategy

When discontinuing duloxetine after more than 3 weeks of treatment, taper gradually over at least 2-4 weeks. 2, 3, 1

• For patients with a history of withdrawal symptoms, use a slower taper over 3-4 weeks with smaller dose decrements (e.g., 120 mg → 100 mg → 80 mg → 60 mg) 2
• Use small increments at intervals that allow adequate observation, usually at least a week at each dose level 2

Discontinuation Symptoms

Common discontinuation symptoms include dizziness, headache, nausea, diarrhea, paresthesia, irritability, vomiting, insomnia, anxiety, hyperhidrosis, and fatigue. 1

---

Clinical Pearls

Mechanism and Onset

The analgesic effectiveness of duloxetine is independent of its antidepressant activity, and the effective analgesic dose is often lower than that required to treat depression. 3

• The onset of analgesic action typically occurs earlier than antidepressant effects 3
• Duloxetine is frequently used as a coanalgesic in combination with opioids for neuropathic pain components 3

Efficacy Data

For diabetic peripheral neuropathy, duloxetine 60 mg daily achieves ≥50% pain reduction in 12 weeks with a number needed to treat of 5. 8, 6

• For fibromyalgia, the number needed to treat is 8 at 12 weeks 8, 6

Common Pitfalls

Nausea is the most common adverse effect, occurring in approximately 38% of patients at 60 mg daily, but occurs less frequently (16%) when treatment is initiated at 30 mg daily. 4, 7

• Most adverse events are mild to moderate in severity 6, 9
• Approximately 16% of patients discontinue due to adverse effects 6
• Serious adverse events are rare 6, 9